Search research articles
Contact Us
Filters
Showing results (1141-1150 of 1,242) with videos related to
Page
of 125
Sort By:
Journal of Pain Research
|
April 2, 2026
The American Society of Pain and Neuroscience (ASPN) Evidence-Based Consensus Recommendations on Programming and Coding Implantable Spinal Cord Stimulation Devices for Treatment of Chronic Intractable Pain
Timothy R Deer, Ali Nairizi, Corey W Hunter, et al.
Clinical Anatomy (New York, N.Y.)
|
February 26, 2022
Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: Recommendations from Anatomical Journal Editors-in-Chief
Joe Iwanaga, Vishram Singh, Sén Takeda, et al.
Biological Psychiatry
|
September 8, 2022
Comparative Transcriptional Analyses in the Nucleus Accumbens Identifies RGS2 as a Key Mediator of Depression-Related Behavior
Alexia V Williams, Catherine J Peña, Stephanie Ramos-Maciel, et al.
Communications Chemistry
|
January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors
Nishma Gupta, Nicole Trainor, Mona Radwan, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases
Jay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 18, 2002
CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships
Dean A Wacker, Joseph B Santella, Daniel S Gardner, et al.
ACS Medicinal Chemistry Letters
|
January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer
Audris Huang, Lata Jayaraman, Aberra Fura, et al.
ACS Chemical Neuroscience
|
July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists
Mark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Nature Communications
|
October 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo
Christiane Kofink, Nicole Trainor, Barbara Mair, et al.
Science (New York, N.Y.)
|
July 2, 2026
Manipulation of protein translation and stem cell self-renewal by CRISPR activation of rRNA transcription
Maximilian Wiesbeck, Emilie L Alard, Florencia Merino, et al.
Page
of 125
Search research articles
Search
Showing results (1141-1150 of 1,242) with videos related to
Sort By:
Page
of 125
Journal of Pain Research
|
April 2, 2026
The American Society of Pain and Neuroscience (ASPN) Evidence-Based Consensus Recommendations on Programming and Coding Implantable Spinal Cord Stimulation Devices for Treatment of Chronic Intractable Pain
Timothy R Deer, Ali Nairizi, Corey W Hunter, et al.
Clinical Anatomy (New York, N.Y.)
|
February 26, 2022
Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: Recommendations from Anatomical Journal Editors-in-Chief
Joe Iwanaga, Vishram Singh, Sén Takeda, et al.
Biological Psychiatry
|
September 8, 2022
Comparative Transcriptional Analyses in the Nucleus Accumbens Identifies RGS2 as a Key Mediator of Depression-Related Behavior
Alexia V Williams, Catherine J Peña, Stephanie Ramos-Maciel, et al.
Communications Chemistry
|
January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors
Nishma Gupta, Nicole Trainor, Mona Radwan, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases
Jay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 18, 2002
CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships
Dean A Wacker, Joseph B Santella, Daniel S Gardner, et al.
ACS Medicinal Chemistry Letters
|
January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer
Audris Huang, Lata Jayaraman, Aberra Fura, et al.
ACS Chemical Neuroscience
|
July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists
Mark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Nature Communications
|
October 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo
Christiane Kofink, Nicole Trainor, Barbara Mair, et al.
Science (New York, N.Y.)
|
July 2, 2026
Manipulation of protein translation and stem cell self-renewal by CRISPR activation of rRNA transcription
Maximilian Wiesbeck, Emilie L Alard, Florencia Merino, et al.
Page
of 125